点击图片查看原图

Human OX40 Ligand / TNFSF4 Protein, Fc Tag

产品价格: ¥18000.00

最小起订量:暂无 可售数量:暂无

发货时限:
暂无
所在地区:
全国
有效期至:
长期有效
最后更新:
2021-05-26 01:30:03
浏览次数:
271

产品详情

品牌名称:
分子量:42.9 kDa纯度:>95% as determined by SDS-PAGE.内毒素:Less than 1.0 EU per μg of the Human OX40 Ligand, Fc Tag by the LAL method.Buffer:50 mM tris, 100 mM glycine, pH7.5生物活性:Measured by its binding ability in a functional ELISA.Immobilized Human OX40, His Tag (Cat# OX0-H5224) at 2 μg/mL (100 μl/well) can bind Human OX40 Ligand, Fc Tag (Cat# OXL-H526x ) with a linear range of  1-10 ng/mL.产品特性:Human OX40 Ligand, Fc Tag is fused with a human IgG1 Fc tag at the N-terminus, and has a calculated MW of 42.9 kDa. The predicted N-terminus is Pro. The reducing (R) protein migrates as 53 kDa in SDS-PAGE  due to glycosylation.产品背景:Members of the dickkopf-related protein family (DKK-1, -2, -3, and -4) are secreted proteins with two cysteine-rich domains separated by a linker region. And DKK3 has been proposed as tumour suppressor gene and a marker for tumour blood vessels. DKK3 is the only DKK family member abundantly expressed in normal lung, but silenced by promoter hypermethylation in a large fraction of lung cancer cell lines and lung tumors. Downregulation of DKK3 was correlated with tumor progression and expression of nuclear beta-catenin in lung tumors. Ectopic expression of DKK3 in lung cancer cells with DKK3 hypermethylation induced apoptosis and inhibited TCF-4 activity as well as nuclear accumulation of beta-catenin and expression of TCF-4 targets c-Myc and cyclin D1. DKK3 modulates FGF and Activin/Nodal signaling to regulate mesoderm induction during early Xenopus development, was reported. 
SDS-PAGE

免责声明

本网页所展示的有关【Human OX40 Ligand / TNFSF4 Protein, Fc Tag】的信息/图片/参数等由的会员【 】提供,由【生物实验采购网】会员【 】自行对信息/图片/参数等的真实性、准确性和合法性负责,本平台(本网站)仅提供展示服务,请谨慎交易,因交易而产生的法 律关系及法律纠纷由您自行协商解决,本平台(本网站)对此不承担任何责任。您在本网页可以浏览【Human OX40 Ligand / TNFSF4 Protein, Fc Tag】有关的信息/图片/价格等及提供 【Human OX40 Ligand / TNFSF4 Protein, Fc Tag】的商家公司简介、联系方式等信息。

在您的合法权益受到侵害时,请您致电,我们将竭诚为您服务,感谢您对【生物实验采购网】的关注与支持!

网站首页 | 关于我们 | 联系方式 | 使用协议 | 版权隐私 | 网站地图  |  排名推广  |  广告服务  |  积分换礼  |  网站留言  |  RSS订阅  |  违规举报
 
免责声明:本站有部分内容来自互联网,如无意中侵犯了某个媒体 、公司 、企业或个人等的知识产权,请来电或致函告之,本网站将在规定时间内给予删除等相关处理。